Status:
COMPLETED
Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer
Lead Sponsor:
University Health Network, Toronto
Conditions:
Endometrial Cancer
Eligibility:
FEMALE
20-90 years
Phase:
NA
Brief Summary
The surgical management of high-risk endometrial cancer often involves an extensive operation to remove lymph nodes as sites of possible cancer spread. 18F-FDG PET/CT imaging is increasingly being us...
Eligibility Criteria
Inclusion
- Women with adenocarcinoma of the endometrium with one of the following subtypes:
- Serous
- Clear Cell
- Carcinosarcoma (MMMT)
- High grade endometrioid
- Clinical stage 1 or 2
- Patients who have signed an approved informed consent.
- Patients who will undergo surgery that includes a hysterectomy and/or hysterectomy, bilateral salpingo-oophorectomy, bilateral pelvic and para-aortic lymph node
Exclusion
- Patients with previous retroperitoneal surgery
- Patients with previous history of pelvic/abdominal radiation
- Any patient treated with neoadjuvant chemotherapy and/or radiation
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01467219
Start Date
January 1 2012
End Date
March 1 2014
Last Update
June 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network - Princess Margaret Cancer Center
Toronto, Ontario, Canada, M5T 2M9